Fabtech Technologies Q2 FY27: PAT ₹4.21 & Rev ₹74.98

Investor Takeaways

Revenue grew 10% YoY to ₹74.98 crores in Q1 FY27

Net profit turned around from ₹6.13 crore loss to ₹4.21 crore profit

EBITDA margin improved to 9.5% from negative EBITDA in the prior year

Order book stands at ₹900+ crores with ₹3,800 crores in hot leads

Finance costs declined 36% to ₹0.86 crores, contributing to profitability

Overall Tone: Positive based on the numbers only.

Key Financial Highlights

Metric	Value	YoY Change
Revenue	₹74.98 Cr	+10%
Net Profit	₹4.21 Cr	Turnaround from ₹6.13 Cr loss
EBITDA Margin	9.5%	From negative EBITDA
OPM	Not available	N/A

What Changed

Fabtech Technologies Limited demonstrated a significant turnaround in Q1 FY27, reporting revenue of ₹74.98 crores, up 10% year-on-year. The company posted a net profit of ₹4.21 crores, reversing a ₹6.13 crore loss in the same quarter of the previous fiscal year. This profitability improvement was supported by expansion in Africa and KSA markets, alongside operational efficiencies. EBITDA margin turned positive at 9.5%, compared to negative EBITDA in the prior year. Cost of Goods Sold decreased by 3.35% to ₹41.62 crores, while finance costs declined 36% to ₹0.86 crores, further easing the expense burden. The order book remains robust at ₹900+ crores, with ₹3,800 crores in hot leads indicating sustained demand momentum. Management expects steady performance in Q2, with stronger growth anticipated in Q3 and Q4, targeting 20-25% organic growth for the full fiscal year.

Peer Comparison

Company	P/E	ROE	ROCE	Market Cap (₹ Cr)
Fabtech Technologies Limited	Not available	Not available	Not available	681.08
Sun Pharmaceutical Industries Limited	41.28	15.11%	20.34%	4,50,643.09
Divi's Laboratories Limited	72.41	16.56%	22.09%	1,79,470.03
Torrent Pharmaceuticals Limited	80.06	N/A	N/A	1,49,108.91

Fabtech’s market capitalization is significantly lower than its peers, reflecting its smaller scale. However, its recent profitability turnaround and improving margins suggest potential for margin expansion and market share gains, though valuation multiples of peers indicate higher investor expectations for growth and profitability sustainability.

Risks & Concerns

No specific risks identified in the provided filing.

No debt-to-equity ratio or leverage metrics disclosed.

Reliance on African and KSA markets for growth may expose the company to geopolitical or regulatory risks not detailed in the filing.

Quarterly Trend

Quarter	Revenue (₹ Cr)	Net Profit (₹ Cr)	OPM%
Q1 FY27	74.98	4.21	Not available

Note: Quarterly trend data is limited to Q1 FY27 as per provided information. No prior quarter comparisons are available.

📄 View Original Announcement (PDF)

📊 Stock Analysis — FABTECH ✨ Ask AI About This

About Fabtech Technologies Limited (FABTECH)

Healthcare · Healthcare Equipment & Supplies · Listed on NSE

Market Cap: ₹681.08 Cr

View full FABTECH stock details →

📡 Get AI alerts when FABTECH files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track FABTECH — Free

💡 Ask AI about this filing

"How will the ₹900+ crore order book convert to revenue over the next two years?" "What specific cost initiatives drove the 36% reduction in finance costs?" "What is the expected timeline for profitability in the UAE FTS segment?"

Ask AI Free →

📊 More FABTECH filings

See all FABTECH filings →

🔥 Also filed on 24 July 2026

CGPOWER CG Power and Industrial Solutions Limited Financial Results OMAXAUTO Omax Autos Limited Financial Results NITCO Nitco Limited Corporate Action LENSKART Lenskart Solutions Limited Annual Report ALLDIGI Alldigi Tech Limited Financial Results RKFORGE Ramkrishna Forgings Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when FABTECH files new disclosures

Track FABTECH filings, board meetings, and corporate actions. Free email alerts at 5 PM.